EUVIMEDEUVIMED entdecken
Open Access

Epigenetic Reprogramming Drives Epithelial Disruption in Chronic Obstructive Pulmonary Disease

Epigenetisches Reprogrammieren treibt die epitheliale Störung bei chronisch obstruktiver Lungenerkrankung voran

Bonnie H Yeung-Luk, Ara Wally, Carter Swaby, Sofia Jauregui, Esther Lee, Rachel Zhang, Daniel Chen, Sean H Luk, Nisha Upadya, Ethan Tieng, Kai Wilmsen, Ethan Sherman und 11 weitere

American Journal of Respiratory Cell and Molecular Biology · 01.03.2024 · 70 (3) · 165-177

DOI: 10.1165/rcmb.2023-0147oc ↗

Auf einen Blick

Die Studie zeigt einen epigenetischen Mechanismus für den Verlust von CDH1/E-Cadherin bei COPD. In humanen Lungenschnitten reduzierte 5-Aza-2′-desoxycytidin Zellschaden und Luftraumerweiterung.

Fragestellung

Führt epigenetisches Reprogrammieren von CDH1/E-Cadherin bei COPD zu einer Störung der epithelialen Integrität?

Methode

Untersuchung an differenzierten primären humanen Atemwegsepithelzellen, genetisch veränderten Maus-Tracheaepithelzellen sowie Maus- und Human-Lungenschnitten.

Ergebnisse

Bei COPD war der CDH1-Verlust mit erhöhter DNA-Methylierung am CDH1-Enhancer D und verminderter TET1-Expression verbunden. 5-Aza-2′-desoxycytidin verringerte Zellschaden und Luftraumerweiterung in COPD-Lungenschnitten.

Schlussfolgerung der Autor:innen

Die Autor:innen beschreiben einen neuen Mechanismus, über den epigenetische Modifikationen das Gewebe-Remodeling in menschlichen COPD-Lungen umkehren können.

Kernaussagen

  • CDH1-Verlust bei COPD mit erhöhter DNA-Methylierung verbunden
  • 5-Aza-2′-desoxycytidin verringerte Zellschaden in COPD-Lungenschnitten
  • Proof-of-concept für einen krankheitsmodifizierenden Ansatz

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, online erschienen am 01.03.2024. Verfasst von Bonnie H Yeung-Luk und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health and Engineering and. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NIH HHS.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic obstructive pulmonary disease (COPD) remains a major public health challenge that contributes greatly to mortality and morbidity worldwide. Although it has long been recognized that the epithelium is altered in COPD, there has been little focus on targeting it to modify the disease course. Therefore, mechanisms that disrupt epithelial cell function in patients with COPD are poorly understood. In this study, we sought to determine whether epigenetic reprogramming of the cell-cell adhesion molecule E-cadherin, encoded by the CDH1 gene, disrupts epithelial integrity. By reducing these epigenetic marks, we can restore epithelial integrity and rescue alveolar airspace destruction. We used differentiated normal and COPD-derived primary human airway epithelial cells, genetically manipulated mouse tracheal epithelial cells, and mouse and human precision-cut lung slices to assess the effects of epigenetic reprogramming. We show that the loss of CDH1 in COPD is due to increased DNA methylation site at the CDH1 enhancer D through the downregulation of the ten-eleven translocase methylcytosine dioxygenase (TET) enzyme TET1. Increased DNA methylation at the enhancer D region decreases the enrichment of RNA polymerase II binding. Remarkably, treatment of human precision-cut slices derived from patients with COPD with the DNA demethylation agent 5-aza-2′-deoxycytidine decreased cell damage and reduced air space enlargement in the diseased tissue. Here, we present a novel mechanism that targets epigenetic modifications to reverse the tissue remodeling in human COPD lungs and serves as a proof of concept for developing a disease-modifying target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveHumansAnimalsMiceCell DifferentiationDNA MethylationDisease ProgressionEpigenesis, GeneticMixed Function OxygenasesProto-Oncogene Proteins

Stichwörter der Autor:innen

CDH1COPDDNA methylationE-cadherinepigenetic

Substanzen

TET1 protein, humanMixed Function OxygenasesProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Environmental Health and Engineering and.
  • Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Department of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
  • Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland.
  • Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California, San Francisco, San Francisco, California.
  • Department of Medicine, University of Michigan, Ann Arbor, Michigan; and.

ORCID-Profile: Yvonne J Huang, Wan-Yee Tang, Venkataramana K Sidhaye

Förderung

  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • NIEHS NIH HHS
  • NIAID NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institute of Environmental Health Sciences
  • National Institute of General Medical Sciences

Zitieren

APA

Yeung-Luk, B. H., Wally, A., Swaby, C., Jauregui, S., Lee, E., Zhang, R., Chen, D., Luk, S. H., Upadya, N., Tieng, E., Wilmsen, K., Sherman, E., Sudhakar, D., Luk, M., Shrivastav, A. K., Cao, S., Ghosh, B., Christenson, S. A., Huang, Y. J., …, & Sidhaye, V. K. (2024). Epigenetic Reprogramming Drives Epithelial Disruption in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology, 70(3), 165-177. https://doi.org/10.1165/rcmb.2023-0147oc

Vancouver

Yeung-Luk BH, Wally A, Swaby C, Jauregui S, Lee E, Zhang R, et al. Epigenetic Reprogramming Drives Epithelial Disruption in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology. 2024;70(3):165-177. doi:10.1165/rcmb.2023-0147oc

BibTeX
@article{YeungLuk2024,
  author = {Yeung-Luk, Bonnie H and Wally, Ara and Swaby, Carter and Jauregui, Sofia and Lee, Esther and Zhang, Rachel and Chen, Daniel and Luk, Sean H and Upadya, Nisha and Tieng, Ethan and Wilmsen, Kai and Sherman, Ethan and Sudhakar, Dheeksha and Luk, Matthew and Shrivastav, Abhishek Kumar and Cao, Shuo and Ghosh, Baishakhi and Christenson, Stephanie A and Huang, Yvonne J and Ortega, Victor E and Biswal, Shyam and Tang, Wan-Yee and Sidhaye, Venkataramana K},
  title = {Epigenetic Reprogramming Drives Epithelial Disruption in Chronic Obstructive Pulmonary Disease},
  journal = {American Journal of Respiratory Cell and Molecular Biology},
  year = {2024},
  volume = {70},
  number = {3},
  pages = {165--177},
  doi = {10.1165/rcmb.2023-0147oc}
}
Kostenlos starten →